cholest-5-ene-3,4-diol has been researched along with Bone Diseases, Metabolic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cransberg, K; Prytuła, A; Raes, A | 1 |
1 review(s) available for cholest-5-ene-3,4-diol and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Drug-metabolizing enzymes CYP3A as a link between tacrolimus and vitamin D in renal transplant recipients: is it relevant in clinical practice?
Topics: Animals; Biomarkers; Bone Density; Bone Diseases, Metabolic; Calcineurin Inhibitors; Cytochrome P-450 CYP3A; Humans; Hydroxycholesterols; Kidney Transplantation; Polymorphism, Single Nucleotide; Tacrolimus; Vitamin D | 2019 |